156 related articles for article (PubMed ID: 37999102)
1. Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer.
Mabuchi S; Komura N; Sasano T; Sakata M; Matsuzaki S; Hisa T; Kamiura S; Morishima T; Miyashiro I
Curr Oncol; 2023 Oct; 30(11):9428-9436. PubMed ID: 37999102
[TBL] [Abstract][Full Text] [Related]
2. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT
Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses.
Lin LM; Lin Q; Liu J; Chu KX; Huang YX; Zhang ZK; Li T; Dai YQ; Li JL
Cancer Med; 2020 Sep; 9(18):6524-6532. PubMed ID: 32705800
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
[TBL] [Abstract][Full Text] [Related]
5. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and treatment comparison in small cell neuroendocrine cervical carcinoma.
Yin ZM; Yu AJ; Wu MJ; Zhu JQ; Zhang X; Chen JH; Yuan SH; Yu H
Eur J Gynaecol Oncol; 2014; 35(3):259-63. PubMed ID: 24984537
[TBL] [Abstract][Full Text] [Related]
7. Twenty-five-year mortality trends of four major histological subtypes of cervical cancer: a population-based study using the Osaka cancer registry data.
Komura N; Mabuchi S; Sasano T; Kamiura S; Morishima T; Miyashiro I
Front Oncol; 2023; 13():1233354. PubMed ID: 38090494
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and outcome of patients with small cell neuroendocrine carcinoma of the uterine cervix: case series and literature review.
Wang Y; Mei K; Xiang MF; Li JM; Xie RM
Eur J Gynaecol Oncol; 2013; 34(4):307-10. PubMed ID: 24020135
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Miyoshi AI; Ueda Y; Kurita T; Kimura T; Yoshino K
Anticancer Res; 2023 Apr; 43(4):1397-1405. PubMed ID: 36974776
[TBL] [Abstract][Full Text] [Related]
11. Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.
Lan-Fang L; Hai-Yan S; Zuo-Ming Y; Jian-Qing Z; Ya-Qing C
Eur J Gynaecol Oncol; 2012; 33(1):68-73. PubMed ID: 22439409
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma.
Intaraphet S; Kasatpibal N; Siriaunkgul S; Sogaard M; Patumanond J; Khunamornpong S; Chandacham A; Suprasert P
Asian Pac J Cancer Prev; 2013; 14(9):5355-60. PubMed ID: 24175825
[TBL] [Abstract][Full Text] [Related]
13. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
[TBL] [Abstract][Full Text] [Related]
14. Small Cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review.
Lu J; Li Y; Wang J
Front Cell Infect Microbiol; 2022; 12():916506. PubMed ID: 35909972
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Aspects of Small Cell Neuroendocrine Carcinoma of the Uterine Cervix: a Multicenter Retrospective Study and Meta-Analysis.
Xu F; Ma J; Yi H; Hu H; Fan L; Wu P; Chen X; Wu X; Yu L; Xing H; Wang W
Cell Physiol Biochem; 2018; 50(3):1113-1122. PubMed ID: 30355937
[TBL] [Abstract][Full Text] [Related]
16. Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
Zhang Y; Ding J; Hua K
J Int Med Res; 2022 Jan; 50(1):3000605211067397. PubMed ID: 34986672
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.
Zhang SW; Luo RZ; Sun XY; Yang X; Yang HX; Xiong SP; Liu LL
BMC Cancer; 2021 Mar; 21(1):332. PubMed ID: 33789601
[TBL] [Abstract][Full Text] [Related]
18. Coexisting squamous cell carcinoma and high-grade neuroendocrine carcinoma, small cell type: a rare collision in cervix.
Kaushal S; Mathur SR; Kumar S
BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29778998
[TBL] [Abstract][Full Text] [Related]
19. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
